Kukje Pharma Co., Ltd.

KRX:002720.KS

4865 (KRW) • At close July 1, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.

2024202320222021202020192018201720162015201420132012201120102009200820072006
Omzet 156,462.823135,372.691126,583.403119,745.569130,394.721111,121.601107,681.163123,310.224120,684.006117,636.992122,426.377120,461.297126,768.061104,857.016131,308.308122,564.775121,637.704103,756.10397,272.857
Kosten van de omzet 73,967.79968,148.04863,329.2765,275.25465,590.07558,136.15358,871.96771,838.72566,903.45364,860.72475,259.68672,687.89382,361.18260,064.24266,575.562,438.04454,051.74446,034.09439,839.65
Brutowinst 82,495.02367,224.64263,254.13354,470.31564,804.64652,985.44848,809.19651,471.553,780.55252,776.26847,166.69147,773.40444,406.87844,792.77464,732.80860,126.73167,585.9657,722.00957,433.207
Brutowinstmarge 0.5270.4970.50.4550.4970.4770.4530.4170.4460.4490.3850.3970.350.4270.4930.4910.5560.5560.59
Onderzoek- en ontwikkelingskosten 1,810.5065,0411,966.8172,772.3373,036.6492,604.0093,591.5443,291.1031,330.6961,066.1671,533.933816.581,027.4990474.433947.58673.677562.942660.922
Algemene en administratieve kosten 4,407.8876,907.154,827.9614,274.1854,457.8565,458.1257,858.0768,496.0838,760.5518,224.1746,993.0686,476.4066,583.6125,364.9955,675.8855,151.7195,230.6784,871.4934,510.744
Verkoop- en marketingkosten 53,593.45936,229.06222,748.39322,053.40316,704.1311,829.8558,624.2479,796.01612,477.99816,081.08916,797.54818,168.1431,749.14718,676.81625,415.2321,371.95322,575.13616,956.90217,581.682
Verkoop-, algemene en administratieve kosten 58,001.34663,412.81527,576.35426,327.58821,161.98617,287.9816,482.32318,292.09921,238.54924,305.26323,790.61624,644.54638,332.75924,041.81131,091.11526,523.67227,805.81421,828.39522,092.426
Overige kosten 15,981.529028,438.43427,046.29334,564.63727,522.702562.36575.348103.777-2,271.27-2,803.693830.793242.814273.1851,400.818993.176691.31587.007-141.473
Bedrijfskosten 75,793.38169,213.78557,981.60556,146.21858,763.27247,414.69145,522.17948,907.32349,811.28750,678.37648,589.64546,726.44659,114.77241,773.29356,718.95251,379.93353,713.38145,038.90244,121.001
Bedrijfsresultaat 6,701.642-1,989.1435,272.527-401.2936,041.374925.9393,287.0182,564.1763,969.2662,097.892-1,422.9541,046.958-14,707.8943,288.5238,013.8578,746.79913,872.5812,683.10713,312.209
Bedrijfsresultaat ratio 0.043-0.0150.042-0.0030.0460.0080.0310.0210.0330.018-0.0120.009-0.1160.0310.0610.0710.1140.1220.137
Totaal overige inkomsten en kosten netto -92.4-4,691.468-527.441565.648-447.795-5,449.316-776.512-511.484-1,454.196-3,779.779-4,253.175-1,142.392-1,127.973-1,410.504-208.875189.869-2,976.254-997.118-843.516
Inkomen voor belasting 6,609.242-6,680.6114,745.086-1,110.2575,593.579121.4412,830.2352,052.6921,770.44-1,681.886-5,676.129522.341-15,835.8661,878.0197,804.9828,936.66810,896.32611,685.98912,468.693
Inkomen voor belasting ratio 0.042-0.0490.037-0.0090.0430.0010.0260.0170.015-0.014-0.0460.004-0.1250.0180.0590.0730.090.1130.128
Belastingkosten 1,403.1631,734.2771,202.313445.5353,399.014,883.253647.3611,014.037971.5014,202.5731,241.123-1,149.5993,104.16908.4933,491.432,077.6674,292.1875,461.3446,325.175
Nettowinst 5,205.175-8,415.1873,557.333-1,555.7912,203.001-4,761.8122,192.6211,092.249773.062-5,942.879-6,932.1062,125.167-18,940.084927.8064,313.5526,859.0016,604.146,224.6456,143.517
Nettowinstmarge 0.033-0.0620.028-0.0130.017-0.0430.020.0090.006-0.051-0.0570.018-0.1490.0090.0330.0560.0540.060.063
WPA (Winst Per Aandeel) 257.76-415.49175.58-76.77103.5-234.89108.0754.237.46-292.38-346.67106.36-947.346.61229.75368.66372.64342.9323.03
Verwaterde WPA 257.76-415.49175.58-76.77103.5-234.89107.9854.237.46-292.38-346.67106.36-947.346.61229.75368.66372.64342.9323.03
EBITDA 11,017.812-1,036.5879,760.4944,078.0739,667.3048,812.8246,027.7195,206.5016,855.8883,242.639-517.9025,124.113-10,030.9266,368.65213,663.67516,367.75615,910.60114,86115,842.299
EBITDA ratio 0.07-0.0080.0770.0340.0740.0790.0560.0420.0570.028-0.0040.043-0.0790.0610.1040.1340.1310.1430.163